查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511978

产后忧郁症治疗药物的市场规模、份额和趋势分析报告：按类型、治疗、给药途径、分销管道、地区和细分市场预测，2024-2030年

Postpartum Depression Drugs Market Size, Share & Trends Analysis Report By Type, Treatment, By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

产后忧郁症治疗药物市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球产后忧郁症治疗药物市场预计将达到15.9亿美元，预测期内复合年增长率预计为9.63%。

全球怀孕人数的增加主要推动了市场的成长。许多女性在生完孩子后患有产后忧郁症（PPD），并且在以后的生活中患重度忧郁症的风险很高。克利夫兰诊所估计，产后忧郁症是一种常见疾病，影响七分之一的女性产后。因此，政府增加对经历分娩和患有 PDD 等情绪障碍的妇女的支持预计将在预测期内增加对药物的需求。

据印度预防与社会医学协会称，每年约有 3000 万妇女怀孕，2700 万妇女分娩。 2022 年 7 月，印度政府启动了多项支持孕妇的计划，包括 Janani Suraksha Yojana (JSY) 和 Janani Shishu Suraksha Karyakaram (JSSK)。根据这些计划，政府提供免费的怀孕相关治疗，包括诊断、药物和其他用品。因此，像 JSSK 和 JSY 这样的倡议将帮助女性完成产后忧郁症治疗，同时推动预测期内的市场成长。

推动产后忧郁症药物采用的另一个重要因素是医疗保健支出的增加，这有助于改善基础设施并增加患者使用医疗保健设施的机会。根据 PETERSON-KFF 健康系统追踪报告，女性每年在怀孕、分娩和产后护理上的花费约为 18,865 美元。这方面差异很大，世界各地区的支出和成本差异很大。增加女性获得 PPD 治疗的机会预计将在未来几年推动市场成长。

产后忧郁症治疗药物市场报告亮点

  • 2023年，产后焦虑类别占市场最大份额。这是由于该疾病的高治疗率以及已开发国家和新兴国家的盛行率不断上升。
  • 根据治疗类型，荷尔蒙疗法领域预计在预测期内将以最快的复合年增长率成长。这可以归因于新荷尔蒙药物的开发和商业化，以及小型医院和机构越来越多地采用它们来治疗 PDD。
  • 2023年，根据途径，口服製剂占据最大的市占率。这一优势是由于全球疾病的盛行率和发病率不断增加、产品的丰富性以及对新型口服学名药治疗的需求不断增长。
  • 根据2023年的分销管道，医院药房部门占据最大的市场份额。背后的原因包括医院治疗率、患者相对于其他医疗机构更喜欢在医院接受PDD治疗，以及就诊患者数量的增加。
  • 由于先进的医疗基础设施、不断上升的疾病盛行率以及有利的法规环境等因素，北美在市场上占据主导地位。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 产后忧郁症治疗药物市场的变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 产后忧郁症治疗药物市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 管道分析

第四章产后忧郁症治疗药物市场：按类型估计和趋势分析

  • 全球产后忧郁症治疗药物市场：类型仪表板
  • 全球产后忧郁症治疗药物市场：类型变异分析
  • 全球产后忧郁症治疗药物市场：依治疗、收益
  • 产后忧郁症
  • 产后焦虑
  • 产后强迫性精神官能症（OCD）
  • 产后创伤后压力症候群（PTSD）
  • 产后恐慌症
  • 预防

第五章产后忧郁症治疗药物市场：依治疗方法估算与趋势分析

  • 全球产后忧郁症治疗药物市场：治疗仪表板
  • 全球产后忧郁症治疗药物市场：治疗变异分析
  • 按治疗分類的收益
  • 药物治疗
  • 荷尔蒙疗法
  • 其他的

第六章 产后忧郁症治疗药物市场：依给药途径估计与趋势分析

  • 全球产后忧郁症治疗药物市场：给药途径仪表板
  • 全球产后忧郁症治疗药物市场：给药途径变化分析
  • 按途径的收益
  • 胃肠外的
  • 口服
  • 其他的

第七章产后忧郁症治疗药物市场：依通路估算与趋势分析

  • 全球产后忧郁症治疗药物市场：分销通路仪表板
  • 全球产后忧郁症治疗药物市场：通路波动分析
  • 按分销管道分類的收益
  • 医院药房
  • 零售药房
  • 其他（网路药局）

第八章产后忧郁症治疗药物市场：按治疗、治疗层级和给药途径进行的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第9章 竞争格局

  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • Sage Therapeutics, Inc.
    • Pfizer Inc.
    • Eli Lilly and Company.
    • GSK plc
    • Merck &Co., Inc.
    • Biogen Inc.
    • Bausch Health Companies Inc.
    • Cipla Inc.
    • Novartis AG.
    • Teva Pharmaceutical Industries Ltd.
Product Code: GVR-4-68040-319-1

Postpartum Depression Drugs Market Growth & Trends:

The global postpartum depression drugs market is anticipated to reach USD 1.59 billion by 2030 and is expected to expand at a CAGR of 9.63% during the forecast period, according to a new report by Grand View Research, Inc. The increasing number of pregnancies worldwide primarily drives market growth. Many women suffer from postpartum depression (PPD) after having a baby and are at high risk of developing major depression later in life. According to the Cleveland Clinic Estimate, postpartum depression is a common condition that affects 1 in 7 women after giving birth to a child. Thus, rising government support for women who had childbirth and are suffering from mood disorders like PDD is expected to boost demand for drugs over the forecast period.

According to the Indian Association of Preventive & Social Medicine, every year, around 30 million women experience pregnancy, and 27 million women have live childbirths. In July 2022, the Government of India launched several schemes to support pregnant women, such as Janani Suraksha Yojana (JSY) and Janani Shishu Suraksha Karyakaram (JSSK). Under these programs, the government offers free of cost treatment related to pregnancy, such as diagnostics, medicines, and other consumables. Thus, initiatives like JSSK and JSY support women in completing treatment such as postpartum depression, simultaneously driving market growth during the forecast period.

Another significant factor driving the adoption of postpartum depression drugs is rising healthcare expenditures, which help to improve infrastructure and improve patient access to healthcare facilities. According to the PETERSON-KFF Health System Tracker report, women spend around USD 18,865 annually on pregnancy, childbirth, and postpartum treatment. There is significant variation. around this, spending and costs vary significantly by region worldwide. The increasing access of women to PPD drug treatment is anticipated to drive market growth in the coming years.

Postpartum Depression Drugs Market Report Highlights:

  • The postpartum anxiety segment held the largest share of the market in 2023. This can be attributed to the disease's high treatment rate and growing prevalence in developed and developing countries.
  • Based on the treatment type, the hormonal therapy segment is expected to grow at the fastest CAGR during the forecast period.This can be attributed to the development and commercialization of new hormonal drugs and increased adoption by smaller hospitals and facilities for the treatment of PDD.
  • In 2023, the oral segment held the largest share of the market based on the route of administration. This dominance can be attributed to the increase in the prevalence and incidence of disease worldwide, the large availability of products, and the rising demand for new generic oral drugs for treatment.
  • The hospital pharmacy segment held the largest share of the market based on distribution channels in 2023. Hospital treatment rates, patient preference for hospitals over other healthcare settings for PDD treatment, and the increasing number of patients visiting hospitals.
  • North America dominated the market owing to factors such as advanced healthcare infrastructure, rising disease prevalence, and favorable regulatory environment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Treatment
    • 1.2.3. Route of Administration
    • 1.2.4. Distribution Channel
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment and Treatment outlook
    • 2.2.2. Route of Administration outlook
    • 2.2.3. Distribution Channel and Availability outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Postpartum Depression Drugs Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of postpartum depression
      • 3.2.1.2. Advancements in drug development
      • 3.2.1.3. Growing awareness and diagnosis
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of treatment
      • 3.2.2.2. Regulatory challenges for new drug approvals
  • 3.3. Postpartum Depression Drugs Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pipeline Analysis

Chapter 4. Postpartum Depression Drugs Market: Treatment Estimates & Trend Analysis

  • 4.1. Global Postpartum Depression Drugs Market: Type Dashboard
  • 4.2. Global Postpartum Depression Drugs Market: Type Movement Analysis
  • 4.3. Global Postpartum Depression Drugs Market by Treatment, Revenue
  • 4.4. Postpartum Blues
    • 4.4.1. Postpartum blues market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Postpartum Anxiety
    • 4.5.1. Postpartum anxiety market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Postpartum Obsessive-Compulsive Disorder (OCD)
    • 4.6.1. Postpartum obsessive-compulsive disorder (OCD) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Postpartum Post-Traumatic Stress Disorder (PTSD)
    • 4.7.1. Postpartum post-traumatic stress disorder (PTSD) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Postpartum Panic Disorder
    • 4.8.1. Postpartum panic disorder market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Preventive
    • 4.9.1. Postpartum psychosis market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Postpartum Depression Drugs Market: Treatment Estimates & Trend Analysis

  • 5.1. Global Postpartum Depression Drugs Market: Treatment Dashboard
  • 5.2. Global Postpartum Depression Drugs Market: Treatment Movement Analysis
  • 5.3. Global Postpartum Depression Drugs Market Estimates and Forecasts, By Treatment, Revenue (USD Million)
  • 5.4. Pharmacotherapy
    • 5.4.1. Pharmacotherapy market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Hormonal Therapy
    • 5.5.1. Hormonal therapy market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Postpartum Depression Drugs Market: Route of Administration Estimates & Trend Analysis

  • 6.1. Global Postpartum Depression Drugs Market: Route of Administration Dashboard
  • 6.2. Global Postpartum Depression Drugs Market: Route of Administration Movement Analysis
  • 6.3. Global Postpartum Depression Drugs Market Estimates and Forecasts, by Route of Administration, Revenue (USD Million)
  • 6.4. Parenteral
    • 6.4.1. Parenteral market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Oral
    • 6.5.1. Oral market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Postpartum Depression Drugs Market: Distribution Channel Estimates & Trend Analysis

  • 7.1. Global Postpartum Depression Drugs Market: Distribution Channel Dashboard
  • 7.2. Global Postpartum Depression Drugs Market: Distribution Channel Movement Analysis
  • 7.3. Global Postpartum Depression Drugs Market Estimates and Forecasts by Distribution Channel, Revenue (USD Million)
  • 7.4. Hospital Pharmacy
    • 7.4.1. Hospital pharmacy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Retail Pharmacy
    • 7.5.1. Retail pharmacy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Others (Online Pharmacy)
    • 7.6.1. Others (online pharmacy) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Postpartum Depression Drugs Market: Regional Estimates & Trend Analysis by Treatment, Therapeutic Class, and Route of Administration

  • 8.1. Regional Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Vendor Landscape
    • 9.2.1. List of key distributors and channel partners
    • 9.2.2. Key customers
    • 9.2.3. Key company market share analysis, 2023
    • 9.2.4. Sage Therapeutics, Inc.
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Pfizer Inc.
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Eli Lilly and Company.
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. GSK plc
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Merck & Co., Inc.
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Biogen Inc.
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Bausch Health Companies Inc.
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. Cipla Inc.
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Product benchmarking
      • 9.2.11.4. Strategic initiatives
    • 9.2.12. Novartis AG.
      • 9.2.12.1. Company overview
      • 9.2.12.2. Financial performance
      • 9.2.12.3. Product benchmarking
      • 9.2.12.4. Strategic initiatives
    • 9.2.13. Teva Pharmaceutical Industries Ltd.
      • 9.2.13.1. Company overview
      • 9.2.13.2. Financial performance
      • 9.2.13.3. Product benchmarking
      • 9.2.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America postpartum depression drugs market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 5 North America postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 6 North America postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 7 U.S. postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 9 U.S. postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 10 U.S. postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 11 Canada postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 13 Canada postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 14 Canada postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Mexico postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 16 Mexico postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 17 Mexico postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 18 Mexico postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 19 Europe postpartum depression drugs market, by region, 2018 - 2030 (USD Million)
  • Table 20 Europe postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 22 Europe postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 23 Europe postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24 Germany postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 25 Germany postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 26 Germany postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 27 Germany postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 28 UK postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 29 UK postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 30 UK postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 31 UK postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 32 France postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 33 France postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 34 France postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 35 France postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 36 Italy postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 37 Italy postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 38 Italy postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 39 Italy postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 40 Spain postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 41 Spain postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 42 Spain postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 43 Spain postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 44 Denmark postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 45 Denmark postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 46 Denmark postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 47 Denmark postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 48 Sweden postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 49 Sweden postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 50 Sweden postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 51 Sweden postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52 Norway postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 53 Norway postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 54 Norway postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 55 Norway postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific postpartum depression drugs market, by region, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 59 Aisa Pacific postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61 China postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 62 China postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 63 China postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 64 China postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 65 Japan postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 66 Japan postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 67 Japan postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 68 Japan postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 69 India postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 70 India postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 71 India postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 72 India postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 73 South Korea postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 74 South Korea postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 75 South Korea postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 76 South Korea postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 77 Australia postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 78 Australia postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 79 Australia postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 80 Australia postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 81 Thailand postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 82 Thailand postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 83 Thailand postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 84 Thailand postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 85 Latin America postpartum depression drugs market, by region, 2018 - 2030 (USD Million)
  • Table 86 Latin America postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 87 Latin America postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 88 Latin America postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 89 Latin America postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 90 Brazil postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 91 Brazil postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 92 Brazil postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 93 Brazil postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 94 Argentina postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 95 Argentina postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 96 Argentina postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 97 Argentina postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 98 MEA postpartum depression drugs market, by region, 2018 - 2030 (USD Million)
  • Table 99 MEA postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 100 MEA postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 101 MEA postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 102 MEA postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 103 South Africa postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 104 South Africa postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 105 South Africa postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 106 South Africa postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 111 UAE postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 112 UAE postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 113 UAE postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 114 UAE postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 115 Kuwait postpartum depression drugs market, by type, 2018 - 2030 (USD Million)
  • Table 116 Kuwait postpartum depression drugs market, by treatment, 2018 - 2030 (USD Million)
  • Table 117 Kuwait postpartum depression drugs market, by route of administration, 2018 - 2030 (USD Million)
  • Table 118 Kuwait postpartum depression drugs market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Postpartum depression drugs market: market outlook
  • Fig. 14 Postpartum depression drugs competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Postpartum depression drugs market driver impact
  • Fig. 18 Postpartum depression drugs market restraint impact
  • Fig. 19 Postpartum depression drugs market: Type movement analysis
  • Fig. 20 Postpartum depression drugs market: Type outlook and key takeaways
  • Fig. 21 Postpartum blues market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Postpartum anxiety market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Postpartum obsessive-compulsive disorder (OCD) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Postpartum post-traumatic stress disorder (PTSD) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Postpartum panic disorder market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Postpartum psychosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Postpartum depression drugs market: Treatment movement analysis
  • Fig. 28 Postpartum depression drugs market: Treatment outlook and key takeaways
  • Fig. 29 Pharmacotherapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Hormonal therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Postpartum depression drugs market: Route of administration movement analysis
  • Fig. 33 Postpartum depression drugs market: Route of administration outlook and key takeaways
  • Fig. 34 Parenteral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Postpartum depression drugs market: Distribution Channel movement analysis
  • Fig. 38 Postpartum depression drugs market: Distribution Channel outlook and key takeaways
  • Fig. 39 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Others (online pharmacy) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Global Postpartum Depression Drugs market: Regional movement analysis
  • Fig. 43 Global Postpartum Depression Drugs market: Regional outlook and key takeaways
  • Fig. 44 Global Postpartum Depression Drugs market share and leading players
  • Fig. 45 North America, by country
  • Fig. 46 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. key country dynamics
  • Fig. 48 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Canada key country dynamics
  • Fig. 50 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Mexico key country dynamics
  • Fig. 52 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UK key country dynamics
  • Fig. 55 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Germany key country dynamics
  • Fig. 57 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 France key country dynamics
  • Fig. 59 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Italy key country dynamics
  • Fig. 61 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Spain key country dynamics
  • Fig. 63 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Denmark key country dynamics
  • Fig. 65 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Sweden key country dynamics
  • Fig. 67 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Norway key country dynamics
  • Fig. 69 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 China key country dynamics
  • Fig. 72 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Japan key country dynamics
  • Fig. 74 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 India key country dynamics
  • Fig. 76 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Thailand key country dynamics
  • Fig. 78 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 South Korea key country dynamics
  • Fig. 80 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Australia key country dynamics
  • Fig. 82 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Brazil key country dynamics
  • Fig. 85 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Argentina key country dynamics
  • Fig. 87 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 South Africa key country dynamics
  • Fig. 90 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Saudi Arabia key country dynamics
  • Fig. 92 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 UAE key country dynamics
  • Fig. 94 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Kuwait key country dynamics
  • Fig. 96 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Market share of key market players- postpartum depression drugs market